AstraZeneca Newsroom

AstraZeneca Target Cut to GBP120 From GBP140 by Intron Health

Dow Jones01:41 ET

AstraZeneca Cut to Hold From Buy by Intron Health

Dow Jones01:41 ET

TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $95

Moomoo NewsOct 8 04:32 ET

Goldman Sachs Sticks to Its Buy Rating for AstraZeneca (AZN)

TipRanksOct 8 02:55 ET

Buy Rating on Arcus Biosciences for Innovative CcRCC Treatment and Strategic AstraZeneca Collaboration

TipRanksOct 7 07:57 ET

AstraZeneca (AZN) Receives a Hold From Jefferies

TipRanksOct 3 02:27 ET

AstraZeneca: Strong Sales and Robust Pipeline Underpin Buy Rating

TipRanksOct 2 05:18 ET

Citi Sticks to Their Buy Rating for AstraZeneca (AZN)

TipRanksSep 30 15:19 ET

Erste Group Downgrades AstraZeneca(AZN.US) to Hold Rating

Moomoo NewsSep 30 08:34 ET

AstraZeneca's Market Position and Drug Pipeline Sustain Buy Rating Despite TB01 Trial Results

TipRanksSep 23 06:38 ET

AstraZeneca: Strong Oncology Pipeline Fuels Growth and Outperformance – Buy Rating Endorsed

TipRanksSep 18 05:30 ET

UBS Sticks to Its Sell Rating for AstraZeneca (AZN)

TipRanksSep 16 02:29 ET

AstraZeneca Cut to Sell From Hold by Deutsche Bank

Dow JonesSep 13 02:31 ET

AstraZeneca Target Cut to 10500p From 11000p by Deutsche Bank

Dow JonesSep 13 02:31 ET

Kepler Capital Sticks to Their Hold Rating for AstraZeneca (AZN)

TipRanksSep 11 21:48 ET

BMO Capital Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $89

Moomoo NewsSep 11 15:31 ET

AstraZeneca Analyst Ratings

BenzingaSep 11 13:52 ET

Erste Group Upgrades AstraZeneca(AZN.US) to Buy Rating

Moomoo NewsSep 11 07:33 ET

AstraZeneca Buy Rating Affirmed: Anticipated FDA Approval of Dato and Long-Term Growth Potential

TipRanksSep 11 03:27 ET

AstraZeneca's Promising NSCLC Treatment: A Buy Rating Amidst Breakthrough Developments

TipRanksSep 10 03:59 ET